Epithelial-mesenchymal transition (EMT) and its reverse mesenchymal-epithelial transition (MET) that appear to be closely associated with metastasis 6 and the acquisition of stem-cell properties by cancer cells 7 are the classical examples of phenotypic plasticity in biological systems. EMT, first discovered by Greenburg and Hay, 8 is, in fact, a normal process in development and wound healing, in which epithelial cells undergo multiple biochemical changes that enable them to assume a mesenchymal phenotype which includes a loss of apico-basal polarity and cell-cell attachments to gain migratory capacity, invasiveness, and increased resistance to apoptosis. 9, 10 Based on the biological context in which they occur, three different types of EMTs have been identified with quite different functional consequences.
INTRODUCTION
State or phenotypic switching is a fundamental physiological process, in which a cell/organism undergoes spontaneous, and potentially reversible, transitions between different phenotypes. Thus, phenotypic plasticity is a key feature of the development and normal function of cells within most multicellular organisms that enables the cell to respond to various intrinsic and external cues and stimuli in a concerted fashion, enabling them to "make" appropriate cellular decisions. 1 Cancer cells not only retain this plasticity but also exploit it for opportunistic adaptation and progression of the disease from transformation to metastasis, which accounts for >90% of cancer-related deaths. 2 Furthermore, phenotypic plasticity allows cancer to beget stem cell-like cells (the so-called cancer stem cells (CSCs) or Tumor Initiating cells) that are thought to be the main cause of therapeutic resistance and disease recurrence. 3, 4 CSCs that arise from somatic cells (nonstem cell cancer cells) are similar to normal stem cells in their ability to self-renew and to generate large populations of differentiated progeny. However, in contrast to the irreversible and hierarchical organization that is generally believed to be the mode of normal tissue homeostasis, phenotypic plasticity allows cancer cells to dynamically enter into and exit the stem-cell state. 5 Thus, it is critical to understand the mechanisms underlying phenotypic plasticity in cancer and whether phenotypic changes resulting from this plasticity can be reversed so that ultimately, this knowledge can be used to develop new and effective cancer therapeutics. origin to acquire a fully mesenchymal phenotype (M phenotype), others may display mesenchymal characteristics while still maintaining an epithelial identity (E/M phenotype). 11 In other words, such cells display a hybrid phenotype that is hypothesized to be metastable 12 or in our models, stabilized by OVOL expression. More importantly, cells with the hybrid phenotype have maximum cellular plasticity, possess heightened tumor-initiating properties, 13, 14 and are detected in several cancers including PCa, where they can migrate to distant locations via the bloodstream by moving collectively as a cluster of Circulating Tumor Cells (CTCs). [15] [16] [17] [18] Such CTC clusters have been reported to have up to 50× greater potential for metastasis than individual CTCs, 19 making them the bad actors in metastasis.
In this Special Issue article, we first discuss phenotypic plasticity in PCa. We identify the key factors implicated in EMT/MET and highlight the fact that they are predicted to be intrinsically disordered proteins (IDPs). Next, we discuss the possibility that phenotypic switching could be analogous to a phase transition phenomenon. It is driven by "noise" resulting from the conformational dynamics of the IDPs and contributes to the rewiring of the cell's protein interaction network (PIN). Thus, contrary to conventional wisdom, phenotypic switching may occur due to events that are stochastic rather than merely deterministic in nature. We conclude by suggesting that targeting IDPs may be a new strategy to gain additional insights and develop novel treatments for PCa.
EMT IN PCA
In PCa, epithelial disease is initially seen within the prostate, but as the disease progresses, markers for the mesenchymal phenotype become more apparent. 20 Mesenchymal cells attach more strongly to the extracellular matrix (ECM) and are able to act as path generators by secreting matrix metalloproteinases (MMPs). 21 MMPs degrade the extracellular matrix (ECM) and disrupt cell-cell and cell-ECM interactions, thereby promoting migration and invasion. 22 Prostatic mesenchymal cells migrate from the primary tumor site and invade the bloodstream to metastasize to distant locations with the most frequent involvement being bone (90%), lung (46%), liver (25%), pleura (21%), and the adrenals (13%). 23 It is tacitly assumed that these mesenchymal cells then become dormant and after a prolonged period of dormancy, which can last for decades, an unknown trigger causes the reverse transition, MET. 24, 25 MET enables tumor growth and leads to a clinically significant metastasis. Metastatic lesions can then re-seed the primary tumor resulting in a vicious cycle. Thus, EMT and MET serve as critical processes for the initial invasion and migration, and acceleration of the later stages of metastatic colonization and growth, respectively, are ideal examples of phenotypic plasticity in PCa and underscore their clinical importance.
A change from an epithelial to a mesenchymal phenotype coincides with a large number of genetic, epigenetic, and structural changes within the cell (Figure 1) . Mesenchymal cells become elongated, lose cell-cell adhesions, and become motile. The most well-known target in epithelial cells is E-cadherin (CDH1), a cell membrane protein that allows for cell-cell attachment via a Ca 2+ -dependent binding with E-cadherin molecules on adjacent cells. In a normal prostate epithelial cell, E-cadherin is also connected internally with actin filaments. 26 Changes in the cytoskeleton are most evident within the intermediate filaments, which changes from keratin to vimentin (VIM) providing the mesenchymal cells with their structure and contributing to motility. 27, 28 Notwithstanding the differences in the types of EMTs, the phenotypic switch from E to M is mostly regulated by a common set of genes and signaling pathways. Among the signaling pathways that are observed to play critical roles are the transforming growth factor beta (TGFβ), epidermal growth factor (EGF), hepatocyte growth factor (HGF), Notch, fibroblast growth factor (FGF), hedgehog, Wnt, and insulin-like growth factor (IGF) together with mechanical factors such as extracellular matrix (ECM) density changes which can weaken cell-cell adhesions. 29 Signals from these pathways are often involved in modulating the activities of several transcription factors that form a gene regulatory circuit with positive and negative feedback, and auto-regulatory loops (Figure 2a) , and act very early during EMT before epigenetic changes to DNA, and histones make the transition more stable.
MODEL FORMULATION
The model for the circuit shown in Figure 2a extends the framework presented in a study by Jia et al. 31 by incorporating E-cadherin as an additional component and the mutual inhibition between ZEB1 and E-cadherin (representing the direct transcriptional inhibition of E-cadherin by ZEB1 and the sequestration of beta-catenin on the membrane by E-cadherin, thus restricting the activation of Wnt/beta-catenin pathway that can transcriptionally activate ZEB). 32 The equation for ZEB mRNA presented in the study by Jia et al. 31 was modified to incorporate the term representing the inhibition by E-cadherin (E).
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H Z, represents the shifted Hill function that represents the inhibition of E-cad by ZEB1. ZEB1 can bind to two E-boxes in E-cad promoter region, 32 and the half-life of E-cadherin is about 5-10 h. 20, 21 Correspondingly, the parameters used are:
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THE KEY DRIVERS OF EMT IN PCA
Biochemical evidence suggests that among the transcription factors constituting the EMT gene regulatory circuit in PCa, ZEB1 appears to play a crucial role by acting as a trigger for EMT when it is upregulated. More specifically, ZEB1 represses the expression of epithelial marker genes such as E-cadherin (CDH1) while activating genes that characterize a mesenchymal phenotype such as Vimentin (VIM).
30 ZEB (ZEB1/2) expression itself is positively regulated by the transcription factor SNAIL (SNAI1/2). Further, ZEB directly inhibits and is directly inhibited by the transcription factors OVOL1/2 (OVOL) and microRNA-200c (miR-200c), forming mutually inhibitory feedback loops. In addition, OVOL can inhibit its own transcription, 31 and E-cadherin can indirectly inhibit ZEB 32 ( Figure 2a) . Downregulation of ZEB results in the reversal of EMT, which is known as an MET. Thus, while the mesenchymal (M) phenotype is characterized by elevated expression of ZEB and SNAIL and downregulation of miR-200c, CDH1, and OVOL, the opposite is true for an epithelial (E) phenotype, as also observed in the NCI-60 panel of cell lines that have been divided into E, E/M, and M phenotype based on CDH1/VIM ratio 33, 34 (Figure 2a ). Mechanism-based mathematical modeling of EMT by Lu et al. 35 has elucidated that miR-200/ZEB can act as a three-way switch enabling transitions among the three phenotypes -E, hybrid E/M, and M -each corresponding to distinct levels of miR-200, ZEB1, and CDH1 (Figure 2b) . Incorporating OVOL in the framework, Jia et al. 31 have uncovered a crucial role for OVOL in modulating the phenotypic plasticity of PCa cells. 31 The effect of OVOL can be visualized in terms of a bifurcation diagram of ZEB mRNA levels (Y-axis), when the miR-200/ ZEB/OVOL/E-cadherin circuit is driven by varying SNAIL protein levels (X-axis) (Figure 2c ). This diagram demonstrates how different levels of SNAIL enable transitions among different phenotypes; for example, at low SNAIL levels, cells can adopt either an E or a hybrid E/M phenotype, and therefore, cells with the same genetic background can be expected to resolve into two subpopulations (E and E/M) in a FACS experiment (green-shaded region in Figure 2c) . Similarly, at higher levels of SNAIL, cells can adopt either a hybrid E/M or M phenotype (orange-shaded region in Figure 2c) .
Furthermore, cells in one phenotype can stochastically undergo transition to adopt the other one. These rates of transition depend on how stable or robust a particular phenotype is to network perturbations, and the relative stability can be expressed via the canonical "epigenetic landscape, " a powerful metaphor in developmental biology introduced by Waddington to describe cell fate specification 36 (Figure 2c) . In this metaphorical representation, cells, represented by balls, roll downhill through a landscape of bifurcating valleys. Each new valley represents a possible cell fate and the ridges between the valleys maintain the cell fate once it has been chosen; the deeper the valley, the more stable the phenotype. Thus, to undergo transition from one state (phenotype) to another, cells with distinct phenotypes are separated by an energy barrier and would have to jump out of one valley into another valley, most likely the one adjacent. Thus, an E to M transition is much less likely than an E to E/M transition for low SNAIL levels. When SNAIL levels are low, the valley associated with M is very shallow; consequently, cells that undergo an EMT (i.e., transition to M) are unlikely to stay because the energy to undergo transition back into E/M is very low and thus cells cannot maintain a full-blown M phenotype, rather switch to being hybrid E/M. SNAIL activity may also differ depending on the cofactors and how it is posttranslationally modified, and therefore, can be thought of as two separate signals: one repressing miR-200c and one activating ZEB1 (Figure 2d) . The resulting phase diagram demonstrates the existence of combinations of different distinct phenotypes. In fact, all the three may co-exist as a function of SNAIL's differential repressing or activating activities. 31, 35 The validation of this prediction by mathematical modeling is seen in recent experiments showing that cell lines belonging to multiple cancers can harbor multiple subpopulations corresponding to E, E/M, and M phenotypes. 13, 37 The extent of epithelial or mesenchymal characteristic of a PCa cell is reflected by E-cadherin (CDH1) expression in the cell. The transcription factors to which E-cadherin expression correlates most strongly are OVOL1, OVOL2, and GRHL2 in a panel of 877 different cancer cell lines representing 36 tumor types including PCa. 38, 39 Among all genes, GRHL2 is the only one in the top 10 (Supplementary Table 1) ; however, OVOL1/2 are #41 and #24, respectively (data not shown), and are hypothesized to act interchangeably. On the other hand, there is a strong negative correlation between ZEB1 expression and E-cadherin levels (Supplementary Table 2 shows the top 10 negatively correlated genes) while SNAI1 is only very weakly correlated with E-cadherin (Pearson − 0.18, Spearman − 0.14) (data not shown). These correlations corroborate the modeling results that the ZEB1/ miR-200c feedback loop forms the "decision-making switch" for EMT/MET, while the SNAIL/miR-34 feedback loop by itself behaves as an integrator, restricting aberrant activation of EMT. 27 As shown in Figure 2d , at low SNAIL levels, the E phenotype is dominant and at high levels, the M phenotype is dominant. However, in the intermediate regime of SNAIL, preceding a threshold value for the transition to an M phenotype defines the E/M hybrid phenotype. Together, the modeling of this dynamical system underscores that phenotypic plasticity in the context of EMT/MET is not dependent on a linear upregulation of transcription but rather a phase transition through a bifurcation, indicative of a network rewiring process. The equations that were used in formulating the mathematical model are described in the Model Formulation section.
IDPS AND EMT
A hallmark of the factors implicated in phenotypic switching whether in cancer or in normal cells is that they are IDPs. Thus, for example, the products of most oncogenes such as Jun, Fos, Myc, 40,41 the Yamanaka factors, namely, OCT3/4, SOX2, Myc, NANOG, and KLF4 that induce reprograming of pluripotent stem (iPS) cells, 42 and >90% of the Cancer/Testis Antigens 43 several of which are implicated in EMT 44, 45 are predicted, and in many cases, they have been experimentally verified to be IDPs. [46] [47] [48] [49] Consistent with these observations, we demonstrate here that the key factors implicated in EMT/MET, namely, OVOL1/2, ZEB1, and SNAI1 are also strongly predicted to be IDPs (Figure 3) .
IDPs are proteins that lack a three-dimensional structure; however, many IDPs can undergo transition from disorder to order upon interacting with a target 50, 51 or in response to posttranslational modifications such as phosphorylation. 52 With multiple conformational states and rapid conformational dynamics, they engage in a myriad of often "promiscuous" interactions. These stochastic interactions between IDPs and their partners result in noise, defined as conformational noise, 53 which is an inherent characteristic of IDP interactions. Recent progress has revealed that many biological processes are driven by probabilistic events, underscoring the importance of "noise" in biological systems. 54 While current research on biological noise has focused on low gene copy numbers as the predominant source of noise, noise arising from stochastic protein interactions has not been fully appreciated. Just as transcriptional noise plays an important role in probabilistic differentiation and adaptation, noise inherent in protein interactions may underlie the activation of latent pathways and cellular transformation. Mahmoudabadi et al. have hypothesized that noise due to stochasticity in protein interaction networks (PINs) contributed by the conformational dynamics of IDPs may play a critical role in phenotypic/state switching. 53 Consistent with this argument, there are now numerous examples of remodeling of the IDP conformational ensemble in response to binding and/or posttranslational modifications. For example, while Forman-Kay and co-workers 52 found that phosphorylation can induce folding of an IDP, He et al. 55 found that phosphorylation of PAGE4 can remodel the ensemble to populate a different conformation, both of which have large functional consequences. Together, these observations tend to suggest that contrary to the prevailing wisdom that phenotype specification is highly deterministic, stochasticity may be a confounding factor in specifying the cell fate. This thinking may also help explain how a given cell can reversibly switch phenotypes as seen in EMT and MET or for that matter, a drug-sensitive cell from developing resistance and switching back to drug sensitivity. 56 Indeed, such stochasticity in phenotypic switching is also thought to underlie cellular differentiation, 54 generation of induced pluripotent stem cells (iPS cells), 57 tumor heterogeneity, 58, 59 and emergence of cancer stem cells from nonstem cancer cells. 60 Implicit in this stochastic model, the PIN configuration contains information that specifies the cell's phenotype.
Pursuant to the theoretical framework proposed by Mahmoudabadi et al. Kulkarni et al. suggested that state switching may be analogous to a phase transition phenomenon where noise from the stochastic interactions initiated by the IDPs in response to a specific input allows the system to sample the network interaction space to rewire PINs and activate the previously masked options, resulting in a transition from one state to another, 61 for example, from phenotype A which represents E to phenotype B which represents M. As depicted in Figure 4 , phenotype A is characterized by a specific configuration of its PIN. When subjected to perturbations, the levels of certain IDPs such as ZEB1 and SNAI1 are upregulated and promote promiscuous interactions to rewire the PIN. If the new configurations of the rewired PIN remain within the threshold characteristic of phenotype A, the E phenotype is retained notwithstanding minor fluctuations in the network topology. However, if the search unmasks the latent PIN configurations that cross the threshold, the cell transitions to phenotype B, i.e., M or even E/M. Each cell has the same probability of switching to phenotype B, and once the perturbation exceeds a threshold (vertical line), the majority of cells in the population will be in phenotype B. Of note, depending on the network topology, lowering the perturbation (e.g., repressing ZEB/SNAI1 expression by OVOL/miR-200) can result in the PIN again rewiring itself to the E (default) network configuration, thereby reversing the phenotypic switch (M to E). In this stochastic model, each cell has an equal probability to undergo a specific phenotypic transition in response to the given input.
CONCLUSIONS
In this perspective article, we have briefly summarized new thinking regarding PCa by underscoring the transient nature of the phenotypic plasticity of cancer cells and how plasticity at the molecular level (remodeling of the IDP conformational ensemble) may contribute to it. Thus, it follows from the foregoing that IDPs represent nodal points of phenotypic plasticity in cancer including PCa, and thus, targeting them pharmacologically may represent a new strategy to develop novel therapeutics for PCa. Indeed, at present, one of the most popular therapeutic targets in PCa is the androgen receptor (AR), an IDP. In fact, AR is known to interact with more than 160 different 62 proteins and a large region of the N-terminal half of the molecule (first ~500 amino acids) that includes its powerful transactivation domain is significantly intrinsically disordered. 63, 64 Ironically, however, every AR blockade that is in use in the clinic is directed against its highly structured ligand-binding domain. While initially being very effective in treating PCa, patients typically end up developing drug resistance and therefore, there is a dire need for new therapies. Recent attempts to target the AR disordered region have yielded small molecule inhibitors that attenuate the growth of castrate-resistant PCa xenografts. 65 Other researchers working on c-Myc, another important player in PCa, which is also an IDP, have identified small molecules that disrupt its dimerization with Max. [66] [67] [68] While there can be no guarantee that newer drugs targeting intrinsically disordered regions or proteins will not result in drug resistance, it is important to understand that PINs adapt a scale-free architecture that follows a power law distribution, making them more resilient to perturbations. Therefore, malfunction of critical hubs in the network can incapacitate the network. 69 Thus, identifying IDPs that occupy such critical hubs and can rewire the cancer cell's PIN to exploit its plasticity 70 provides an opportunity for developing new and effective therapeutics. Of note, major efforts to map the Arabidopsis interactome 71, 72 has helped researchers show that certain plant pathogens actually target hub proteins to control the host's cellular machinery, 73 lending credence to our argument.
GLOSSARY OF TERMS
Bifurcation: A splitting of one thing into two. Bifurcation theory is the mathematical study of changes in the qualitative or topological Figure 4 : Schematic representation of phenotypic switching driven by noise in protein interaction networks. Phenotype A represents a normal cell that is characterized by a specific configuration of its protein interaction network (PIN). When subjected to perturbations, the levels of certain intrinsically disordered proteins (IDPs) increase and promote promiscuous interactions to rewire the PIN. If the new configurations of the rewired PIN remain within the threshold characteristic of phenotype A, this phenotype is retained notwithstanding minor fluctuations in the network topology. However, if the search unmasks latent PIN configurations that cross the threshold, the cell transitions to a cancer cell represented by phenotype B. Each cell has the same probability of switching to phenotype B, and once the perturbation exceeds a threshold (vertical line), the majority of cells in the population will be in phenotype B. 
